EGT-001

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEGT-001
Drug Alias NameEGT-001
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEyegene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEyegene Inc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A